MOPP

[1. Acronym for mechlorethamine, Oncovin (vincristine), procarbazine, and prednisone, a chemotherapy regimen used in the treatment of Hodgkin disease.

Molecular Formula: C₈₄H₁₁₃Cl₃N₈O₁₆

InChI: InChI=1/C46H56N4O10.C21H26O5.C12H19N3O.C5H11Cl2N.ClH/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19;1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3;1-8(4-2-6)5-3-7;/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3;4-7,9,13-14H,8H2,1-3H3,(H,15,16);2-5H2,1H3;1H/t28-,37?,38?,39-,42+,43-,44-,45+,46+;14-,15-,18+,19-,20-,21-;;;/m10.../s1/f/h;;15H;;

InChIKey: InChIKey=SVYBPMMLNVMOPS-SHXLOLFKDS
SMILES: CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.CC(C)NC(=O)C1=CC=C(C=C1)CNNC.CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C.CN(CCCl)CCCl.Cl

Names:
    MOPP (combined therapy with nitrogen mustard, vincristine, procarbazine, and Prednisone) and other combined chemotherapy including alkylating agents
    MOPP
    Vincaleukoblastine, 22-oxo-, mixt. with 2-chloro-N-(2-chloroethyl)-N-methylethanamine hydrochloride, 17,21-dihydroxypregna-1,4-diene-3,11,20-trione and N-(1-methylethyl)-4-((2-methylhydrazino)methyl)benzamide
    Vincristine - prednisone - nitrogen mustard - procarbazine mixt.
    113803-47-7
    22-Oxovincaleukoblastine mixt. with 2-chloro-N-(2-chloroethyl)-N-methylethanamine hydrochloride, 17,21-dihydroxypregna-1,4-diene-3,11,20-trione and N-(1-methylethyl)-4-((2-methylhydrazino)methyl)benzamide

Registries:
    PubChem CID 62312
    PubChem ID 199748